333 related articles for article (PubMed ID: 16226325)
1. Ceramide-enriched membrane domains.
Bollinger CR; Teichgräber V; Gulbins E
Biochim Biophys Acta; 2005 Dec; 1746(3):284-94. PubMed ID: 16226325
[TBL] [Abstract][Full Text] [Related]
2. Ceramide and cell death receptor clustering.
Gulbins E; Grassmé H
Biochim Biophys Acta; 2002 Dec; 1585(2-3):139-45. PubMed ID: 12531547
[TBL] [Abstract][Full Text] [Related]
3. Biological aspects of ceramide-enriched membrane domains.
Grassmé H; Riethmüller J; Gulbins E
Prog Lipid Res; 2007; 46(3-4):161-70. PubMed ID: 17490747
[TBL] [Abstract][Full Text] [Related]
4. Rhinoviruses infect human epithelial cells via ceramide-enriched membrane platforms.
Grassmé H; Riehle A; Wilker B; Gulbins E
J Biol Chem; 2005 Jul; 280(28):26256-62. PubMed ID: 15888438
[TBL] [Abstract][Full Text] [Related]
5. TRAIL activates acid sphingomyelinase via a redox mechanism and releases ceramide to trigger apoptosis.
Dumitru CA; Gulbins E
Oncogene; 2006 Sep; 25(41):5612-25. PubMed ID: 16636669
[TBL] [Abstract][Full Text] [Related]
6. Physiological and pathophysiological aspects of ceramide.
Gulbins E; Li PL
Am J Physiol Regul Integr Comp Physiol; 2006 Jan; 290(1):R11-26. PubMed ID: 16352856
[TBL] [Abstract][Full Text] [Related]
7. Acid sphingomyelinase amplifies redox signaling in Pseudomonas aeruginosa-induced macrophage apoptosis.
Zhang Y; Li X; Carpinteiro A; Gulbins E
J Immunol; 2008 Sep; 181(6):4247-54. PubMed ID: 18768882
[TBL] [Abstract][Full Text] [Related]
8. Host defense against Pseudomonas aeruginosa requires ceramide-rich membrane rafts.
Grassmé H; Jendrossek V; Riehle A; von Kürthy G; Berger J; Schwarz H; Weller M; Kolesnick R; Gulbins E
Nat Med; 2003 Mar; 9(3):322-30. PubMed ID: 12563314
[TBL] [Abstract][Full Text] [Related]
9. Ceramide-induced cell death in malignant cells.
Carpinteiro A; Dumitru C; Schenck M; Gulbins E
Cancer Lett; 2008 Jun; 264(1):1-10. PubMed ID: 18353542
[TBL] [Abstract][Full Text] [Related]
10. Ceramide-enriched membrane domains--structure and function.
Zhang Y; Li X; Becker KA; Gulbins E
Biochim Biophys Acta; 2009 Jan; 1788(1):178-83. PubMed ID: 18786504
[TBL] [Abstract][Full Text] [Related]
11. Role of sphingomyelinase and ceramide in modulating rafts: do biophysical properties determine biologic outcome?
Cremesti AE; Goni FM; Kolesnick R
FEBS Lett; 2002 Oct; 531(1):47-53. PubMed ID: 12401201
[TBL] [Abstract][Full Text] [Related]
12. Regulation of death receptor signaling and apoptosis by ceramide.
Gulbins E
Pharmacol Res; 2003 May; 47(5):393-9. PubMed ID: 12676513
[TBL] [Abstract][Full Text] [Related]
13. Doxorubicin enhances TRAIL-induced cell death via ceramide-enriched membrane platforms.
Dumitru CA; Carpinteiro A; Trarbach T; Hengge UR; Gulbins E
Apoptosis; 2007 Aug; 12(8):1533-41. PubMed ID: 17520194
[TBL] [Abstract][Full Text] [Related]
14. Raft ceramide in molecular medicine.
Gulbins E; Kolesnick R
Oncogene; 2003 Oct; 22(45):7070-7. PubMed ID: 14557812
[TBL] [Abstract][Full Text] [Related]
15. Ceramide in bacterial infections and cystic fibrosis.
Grassmé H; Becker KA; Zhang Y; Gulbins E
Biol Chem; 2008 Nov; 389(11):1371-9. PubMed ID: 18783339
[TBL] [Abstract][Full Text] [Related]
16. Ceramide, membrane rafts and infections.
Gulbins E; Dreschers S; Wilker B; Grassmé H
J Mol Med (Berl); 2004 Jun; 82(6):357-63. PubMed ID: 15069600
[TBL] [Abstract][Full Text] [Related]
17. Cell surface ceramide generation precedes and controls FcgammaRII clustering and phosphorylation in rafts.
Abdel Shakor AB; Kwiatkowska K; Sobota A
J Biol Chem; 2004 Aug; 279(35):36778-87. PubMed ID: 15194692
[TBL] [Abstract][Full Text] [Related]
18. Caspase-dependent and -independent activation of acid sphingomyelinase signaling.
Rotolo JA; Zhang J; Donepudi M; Lee H; Fuks Z; Kolesnick R
J Biol Chem; 2005 Jul; 280(28):26425-34. PubMed ID: 15849201
[TBL] [Abstract][Full Text] [Related]
19. Acid Sphingomyelinase-Ceramide System in Bacterial Infections.
Li C; Wang A; Wu Y; Gulbins E; Grassmé H; Zhao Z
Cell Physiol Biochem; 2019; 52(2):280-301. PubMed ID: 30816675
[TBL] [Abstract][Full Text] [Related]
20. Sphingomyelin-ceramide turnover in CD28 costimulatory signaling.
Chan G; Ochi A
Eur J Immunol; 1995 Jul; 25(7):1999-2004. PubMed ID: 7621875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
